Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Enjoy the silence

<< Previous

Bullboard Posts

Next >>

Comment by SPCEO1on Nov 11, 2022 12:08pm

89 Views

Post# 35091682

RE:RE:RE:Enjoy the silence

Trading volume during the third quarter was so low I cannot imagine any of the large institutional holders of the stock were very active in either buying or selling. But the proof is in the pudding and we will know next week.

Our IR officer reports she is still working very hard for all our benefit.

Biobob wrote: Thanks... are we supposed to learn anything about filings soon (nov.15). Also as anyone talk to IR lately or are they just taking messages overthere.

<< Previous

Bullboard Posts

Next >>

2024, a breakthrough year for silver